A pentamidine-treated acquired immunodeficiency syndrome patient associated with sudden onset diabetes mellitus and high tumor necrosis factor α level

Journal of Diabetes and its Complications

Volumn 11, Issue 4, 1997, Pages 256-258

  Ubukata, Eiichi ^a   Mokuda, Osamu ^a   Nagata, Megumi ^a   Ogino, Yoshio ^a   Sakamoto, Yoshikazu ^a   Tanaka, Koushi ^a   Shimizu, Naokata ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GLUCOSE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INSULIN; PENTAMIDINE ISETHIONATE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; FLUID THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; MALE; ORAL DRUG ADMINISTRATION; PANCREAS ISLET BETA CELL; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 0030908370     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)00111-5     Document Type: Article

References (18)

1. Gordin FM, Simon GL, Wofsy CB, Mills J: Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100:495-499, 1984.
2. Hober D, Ajana F, Petit MC, Sartiaux C, Boniface M, Caillaux M, Mouton Y, Wattre P, Maniez-Montreuil M: Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol Immunol 37:785-792.
3. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 259:87-91, 1993.
4. Campbell IL, Iscaro A, Harrison LC: IFN-γ and tumor necrosis factor-α Cytotoxicity to murine islets of Langerhans. J. Immunol 141:2325-2329, 1988.
5. Picarella DE, Kratz A, Li C, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. J Immunol 150:4136-4150, 1993.
6. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL: Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71:152-156, 1990.
7. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor a inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994.
8. Von Sydow M, Sonnerborg A, Gaines H, Strannegard O: Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 7:375-380, 1991.
9. Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A: Production of tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) in patients with AIDS: Enhanced level of TNF-α is related to a higher cytotoxic activity. Clin Exp Immunol 78:329-333, 1989.
10. Mandrup-Poulsen T, Pociot F, Mølvig J, Shapiro L, Nilsson P, Emdal T, Røder M, Kjems LL, Dinarello CA, Nerup J: Monokine antagonism is reduced in patients with IDDM. Diabetes 43:1242-1247, 1994.
11. Osei K, Falko JM, Nelson KP, Stephens R: Diabetogenic effect of pentamidine: In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med 77:41-46, 1984.
12. Bouchard PH, Sai P, Reach G, Caubarrere I, Ganeval D, Assan R: Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 31:40-45, 1982.
13. Conte JE, Upton RA, Phelps RT, Wofsy CB, Zurlinden E, Lin ET: Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS. J Infect Dis 154:923-929, 1986.
14. Collins RJ, Pien FD, Houk JH: Case report: Insulin-dependent diabetes mellitus associated with pentamidine. Am J Med Sci 297:174-175, 1989.
15. Shen M, Orwoll ES, Conte JE, Prince MJ: Pentamidine-induced pancreatic beta-cell dysfunction. Am J Med 86:726-728, 1989.
16. Waskin H, Stehr-Green JK, Helmick CG, Sattler FR: Risk factors for hypoglycemia associated with pentamidine therapy for pneumocystis pneumonia. JAMA 260:345-347, 1988.
17. Goa KL and Campoli-Richards DM: Pentamidine isethionate: a review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in pneumocystis carinii pneumonia. Drugs 33:242-258, 1987.
18. Conte JE, Hollander H, Golden JA: Inhaled or reduced-dose intravenous pentamidine for pneumocystis carinii pneumonia. Ann Inter Med 107:495-498, 1987.